Research
Micronutrients & recovery
Vitamin D3 supplementation (800 IU/day) is the most cost-effective management strategy for sarcopenia in Iran, whereas combination therapies (Protein + Vitamin D3) are not cost-effective despite higher clinical effectiveness.
For managing sarcopenia cost-effectively, Vitamin D3 supplementation (800 IU/day) is the recommended single intervention. While combining it with protein and exercise improves muscle metrics, the added cost makes it economically inefficient for public health systems compared to Vitamin D alone.
ModerateQualifiesMEDIUM confidence
base-case results indicated that vitamin D was the cost-effective strategy... the D strategy was a cost-effective intervention in this evaluation.
Why this rating
It is a cost-utility model based on limited clinical evidence and assumptions (e.g., 90% adherence), not a primary RCT.
Source
Cost-effectiveness analysis of sarcopenia management interventions in Iran
Ali Darvishi et al. · BMC Public Health · 2023
DOI 10.1186/s12889-023-15693-w
unknownCited 13×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Micronutrients & recovery
- Trans fats (industrial trans-fatty acids) are unequivocally harmful and should be completely avoided as they raise LDL-C, TGs, and Apo B while lowering HDL-C.Strong
- For menopausal women with osteoporosis, first-line pharmacologic therapies include alendronate, risedronate, zoledronic acid, and denosumab for the prevention of hip, nonvertebral, and vertebral fractures.Strong
- Folic acid fortification of flour prevents neural tube birth defects, and mandatory fortification is more effective than voluntary supplementation alone.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →